https://orcid.org/0000-0002-8888-1046
Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kai Chu, Yuemei Hu, Hongxing Pan, Jingliang Wu, Dandan Zhu, Mariano M. Young$suffix/text()$suffix/text(), Li Luo, Zhuobiao Yi, Peter C. Giardina, William C. Gruber, Daniel A. Scott & Wendy Watson. (2023) A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Emily K Horn, Matt D Wasserman, Cassandra Hall-Murray, Heather L Sings, Ruth Chapman & Raymond A Farkouh. (2021) Public health impact of pneumococcal conjugate vaccination: a review of measurement challenges. Expert Review of Vaccines 20:10, pages 1291-1309.
Read now
Read now
Articles from other publishers (21)
Xiyu Zhang, Chunting Liu, Zongjun Yi, Linglu Zhao, Zhongju Li, Linhong Yao, Bufang Feng, Liping Rui, Bin Qu, Ming Liu & Fuqiang Cui. (2023) What Works for Controlling Meningitis Outbreaks: A Case Study from China. Vaccines 11:12, pages 1762.
Crossref
Crossref
Aishatu L. Adamu, J. Ojal, Isa A. Abubakar, Kofo A. Odeyemi, Musa M. Bello, Christy A. N. Okoromah, Boniface Karia, Angela Karani, Donald. Akech, Victor Inem, J. Anthony G. Scott & Ifedayo M. O. Adetifa. (2023) The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria. Nature Communications 14:1.
Crossref
Crossref
Luyanda Hlongwa, Jonathan Peter & Elizabeth Mayne. (2023) Value of diagnostic vaccination in diagnosis of humoral inborn errors of immunity. Human Immunology 84:5-7, pages 337-341.
Crossref
Crossref
Takashi Ono, Masahiro Watanabe, Koichi Hashimoto, Yohei Kume, Mina Chishiki, Hisao Okabe, Masatoki Sato, Sakurako Norito, Bin Chang & Mitsuaki Hosoya. (2023) Serotypes and Antibiotic Resistance of Streptococcus pneumoniae before and after the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine for Adults and Children in a Rural Area in Japan. Pathogens 12:3, pages 493.
Crossref
Crossref
Matthias Horn, Christian Theilacker, Ralf Sprenger, Christof von Eiff, Ernestine Mahar, Julia Schiffner-Rohe, Mathias W. Pletz, Mark van der Linden & Markus Scholz. (2023) Mathematical modeling of pneumococcal transmission dynamics in response to PCV13 infant vaccination in Germany predicts increasing IPD burden due to serotypes included in next-generation PCVs. PLOS ONE 18:2, pages e0281261.
Crossref
Crossref
Esra Ekinci, Liesbet Van Heirstraeten, Laura Willen, Stefanie Desmet, Ine Wouters, Helene Vermeulen, Christine Lammens, Herman Goossens, Pierre Van Damme, Jan Verhaegen, Philippe Beutels, Heidi Theeten & Surbhi Malhotra-Kumar. (2023) Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV. Journal of the Pediatric Infectious Diseases Society 12:1, pages 36-42.
Crossref
Crossref
Néhémie Nzoyikorera, Idrissa Diawara, Mostafa Katfy, Khalid Katfy, Fakhreddine Maaloum, Joseph Nyandwi, Houria Belabbes, Naima Elmdaghri & Khalid Zerouali. (2023) Serotype distribution and antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates among adult and elderly population before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco. BMC Infectious Diseases 23:1.
Crossref
Crossref
Matus Macaj, Lubica Perdochova & Janka Jakubikova. (2023) Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008–2019). Vaccine 41:2, pages 452-459.
Crossref
Crossref
Fernanda Raya Tonetti, Patricia Clua, Kohtaro Fukuyama, Guillermo Marcial, Jacinto Sacur, Gabriela Marranzino, Mikado Tomokiyo, Guadalupe Vizoso-Pinto, Apolinaria Garcia-Cancino, Shoichiro Kurata, Haruki Kitazawa & Julio Villena. (2022) The Ability of Postimmunobiotics from L. rhamnosus CRL1505 to Protect against Respiratory Syncytial Virus and Pneumococcal Super-Infection Is a Strain-Dependent Characteristic. Microorganisms 10:11, pages 2185.
Crossref
Crossref
Julie-Anne Lemay, Leah J. Ricketson & James D. Kellner. (2022) Trends in Asymptomatic Nasopharyngeal Streptococcus pneumoniae Carriage with qPCR and Culture Analysis. Microorganisms 10:10, pages 2074.
Crossref
Crossref
Mogens Kilian, Steffen Husby, Jesper Andersen, Zina Moldoveanu, Uffe B. Skov Sørensen, Jesper Reinholdt & Hervé Tettelin. (2022) Induction of Susceptibility to Disseminated Infection with IgA1 Protease-Producing Encapsulated Pathogens Streptococcus pneumoniae, Haemophilus influenzae Type b, and Neisseria meningitidis. mBio 13:3.
Crossref
Crossref
Johnna Perdrizet, Emily K. Horn, Winniefer Nua, Judith Perez-Peralta, Jennifer Nailes, Jaime Santos & Anna Ong-Lim. (2022) A Response to: Letter to the Editor Regarding “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”. Infectious Diseases and Therapy 11:3, pages 1301-1303.
Crossref
Crossref
Daniela Regalado L, Ismar A. Rivera-Olivero, Miguel Angel Garcia-Bereguiain, Leandro Tana, Isabel Hernandez, Jeannete Zurita, Jorge E. VidalEnrique Terán & Jacobus H. de Waard. (2021) Pneumococcal Carriage Among Indigenous Kichwa Children From the Ecuadorian Andes After the 10-Valent Pneumococcal Vaccine Introduction. Pediatric Infectious Disease Journal 40:11, pages e427-e433.
Crossref
Crossref
Michael P. Kostinov, Anrey D. Protasov, Alexandr V. Zhestkov, Natalya E. Yastrebova, Anton M. Kostinov, Anna E. Vlasenko, Valentina B. Polishhuk, Aristitsa M. Kostinova, Elena S. Korovkina, Alexey A. Ryzhov & Anna D. Shmit'ko. (2021) A Randomized Safety Study of 13-Valent Pneumococcal Conjugated Vaccine and Post-Vaccination Immune Response to <em> Streptococcus pneumoniae </em> Serotypes in Adult Patients with Bronchial Asthma and Chronic Obstructive Pulmonary Disease. Annals of the Russian academy of medical sciences 76:3, pages 324-334.
Crossref
Crossref
Sofia Félix, Sara Handem, Sónia Nunes, Ana Cristina Paulo, Catarina Candeias, Carina Valente, Alexandra S. Simões, Sónia T. Almeida, Débora A. Tavares, António Brito-Avô, Hermínia de Lencastre & Raquel Sá-Leão. (2021) Impact of private use of the 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal carriage among Portuguese children living in urban and rural regions. Vaccine 39:32, pages 4524-4533.
Crossref
Crossref
H. P. Ruban & S. V. Struch. (2021) Vaccination as a solution of the issue of resistance S. pneumoniae. Epidemiology and Vaccinal Prevention 20:2, pages 83-92.
Crossref
Crossref
Maria Garcia Quesada, Yangyupei Yang, Julia Bennett, Kyla Hayford, Scott Zeger, Daniel Feikin, Meagan Peterson, Adam Cohen, Samanta Almeida, Krow Ampofo, Michelle Ang, Naor Bar-Zeev, Michael Bruce, Romina Camilli, Grettel Chanto Chacón, Pilar Ciruela, Cheryl Cohen, Mary Corcoran, Ron Dagan, Philippe De Wals, Stefanie Desmet, Idrissa Diawara, Ryan Gierke, Marcela Guevara, Laura Hammitt, Markus Hilty, Pak-Leung Ho, Sanjay Jayasinghe, Jackie Kleynhans, Karl Kristinsson, Shamez Ladhani, Allison McGeer, Jason Mwenda, J. Nuorti, Kazunori Oishi, Leah Ricketson, Juan Sanz, Larisa Savrasova, Lena Setchanova, Andrew Smith, Palle Valentiner-Branth, Maria Valenzuela, Mark van der Linden, Nina van Sorge, Emmanuelle Varon, Brita Winje, Inci Yildirim, Jonathan Zintgraff & Maria Knoll. (2021) Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project. Microorganisms 9:4, pages 738.
Crossref
Crossref
Shamez N Ladhani, Nick Andrews & Mary E Ramsay. (2021) Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK. The Lancet Infectious Diseases 21:4, pages e93-e102.
Crossref
Crossref
Forouzan Khodaei, Anam Ahsan, Mostafa Chamanifard, Mohammad Javad Zamiri & Mohammad Mehdi Ommati. (2020) Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor. Journal of Biochemical and Molecular Toxicology 34:12.
Crossref
Crossref
Andrew Vyse, Christian Theilacker, Heather Sings & Mark Fletcher. (2020) Pneumococcal immunization with conjugate vaccines – are 10-valent and 13-valent vaccines similar?. Future Microbiology 15:8, pages 575-577.
Crossref
Crossref
Zuzana Vančíková. (2020) The Pneumococcus - Innocent colonizer or invasive enemy?. Pediatrie pro praxi 21:1, pages 12-16.
Crossref
Crossref